Harvard Bioscience (HBIO)
NASDAQ:HBIO
Holding HBIO?
Track your performance easily

Harvard Bioscience (HBIO) Ownership - Who Owns Harvard Bioscience?

184 Followers

Harvard Bioscience (HBIO) Ownership Overview

10.81%19.55%1.31%9.42%58.91%
10.81% Insiders
1.31% Other Institutional Investors
9.42% ETFs
58.91% Public Companies and
Individual Investors
The ownership structure of Harvard Bioscience (HBIO) stock is a mix of institutional, retail, and individual investors. Approximately 30.28% of the company’s stock is owned by Institutional Investors, 10.81% is owned by Insiders, and 58.91% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 14, 2024
James W. Green
Ceo,director
xxxxxxxxxxxxx
$29100
Jun 07, 2024
James W. Green
Ceo,director
xxxxxxxxxxxxx
$61400

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$42750
Jun 30, 2024
xxxxxxxxxxxxx
$4108132

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
3,111,091Insider7.13%7,466,618
2,557,500Institution5.86%6,138,000
2,062,073Institution4.73%4,948,975
1,841,679Institution4.22%4,420,030
1,441,450Institution3.31%3,459,480
1,424,349Institution3.27%3,418,438
1,200,000Institution2.75%2,880,000
1,035,689Institution2.37%2,485,654
927,319Institution2.13%2,225,566
556,208Insider1.28%1,334,899

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,841,679Institution4.22%4,420,030
1,200,000Institution2.75%2,880,000
1,035,689Institution2.37%2,485,654
927,319Institution2.13%2,225,566
440,934Institution1.01%1,058,242
384,569Institution0.88%922,966
344,113Institution0.79%825,871
277,680Institution0.64%666,432
252,032Institution0.58%604,877
239,942Institution0.55%575,861

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,261,693Institution2.89%3,393,954
952,121Institution2.18%2,285,090
579,986Institution1.33%1,560,162
262,513Institution0.60%616,906
253,784Institution0.58%609,082
186,801Institution0.43%502,495
125,644Institution0.29%301,546
104,348Institution0.24%245,218
92,800Institution0.21%222,720
78,555Institution0.18%184,604

FAQ

Who Owns Harvard Bioscience (HBIO)?
According to the latest TipRanks data, approximately 1.31% of the company's stock is held by institutional investors, 10.81% is held by insiders, and 58.91% is held by retail investors.
    What percentage of Harvard Bioscience (HBIO) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 1.31% of Harvard Bioscience (HBIO) stock is held by institutional investors.
      What percentage of Harvard Bioscience (HBIO) stock is held by retail investors?
      According to the latest TipRanks data, approximately 58.91% of Harvard Bioscience (HBIO) stock is held by retail investors.
        Who owns the most shares of Harvard Bioscience (HBIO)?
        James W. Green owns the most shares of Harvard Bioscience (HBIO).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis